M
Mark D. Johnson
Researcher at University of Massachusetts Medical School
Publications - 301
Citations - 18425
Mark D. Johnson is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Medicine & Gene. The author has an hindex of 60, co-authored 289 publications receiving 16103 citations. Previous affiliations of Mark D. Johnson include National Institutes of Health & Georgetown University Medical Center.
Papers
More filters
Journal ArticleDOI
Prenatal cocaine exposure alters norepinephrine release from cardiac adrenergic nerve terminals
TL;DR: The results suggest that prenatal cocaine exposure delays the development of the mechanisms responsible for Ca2+ influx during K(+)-induced depolarization and increases the neurosecretory response to intracellular Ca2+.
Journal ArticleDOI
Quantitative evaluation of changes in gait after extended cerebrospinal fluid drainage for normal pressure hydrocephalus.
Felix Yang,Thu-Trang T. Hickman,Megan Tinl,Christine Iracheta,Grace L Chen,Patricia Flynn,Matthew E. Shuman,Tatyana A. Johnson,Rebecca R. Rice,Isaac M. Rice,Robert Wiemann,Mark D. Johnson +11 more
TL;DR: There was no significant difference in presenting gait characteristics between patients who improved after drainage and those who did not, and the degree of improvement after eLCD correlated closely with that observed after shunt placement.
Journal ArticleDOI
Failure of nondepolarizing neuromuscular blockers to inhibit succinylcholine-induced increased intraocular pressure a controlled study
Journal ArticleDOI
Fetal surgery and general anesthesia: a case report and review.
Mark D. Johnson,D. J. Birnbach,Cory Burchman,Michael F. Greene,Sanjay Dattaa,G. W. Ostheimer +5 more
TL;DR: Fetal surgery, in utero, is now a viable option for some congenital conditions due to recent advances in ultrasound and microsurgical technology, and general endotracheal anesthesia may have several advantages in this setting.
Journal ArticleDOI
Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.
Rifaquat Rahman,Paul J. Catalano,David A. Reardon,Andrew D. Norden,Patrick Y. Wen,Eudocia Q. Lee,Lakshmi Nayak,Rameen Beroukhim,Ian F. Dunn,Alexandra J. Golby,Mark D. Johnson,E. Antonio Chiocca,Elizabeth B. Claus,Elizabeth B. Claus,Brian M. Alexander,Nils D. Arvold +15 more
TL;DR: Hospitalization during the CRT phase is common among glioblastoma patients in the temozolomide era and is associated with shorter overall survival, after adjustment for known prognostic factors.